We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Bio-Rad Logo

Bio-Rad

For over six decades, Bio-Rad has served life science research and clinical diagnostics customers worldwide through its global network of operations. Bio-Rad is internationally renowned among academic institutions, pharmaceutical companies and major research institutions for its commitment to quality and customer service.

Latest Bio-Rad Content

Cancer
App Note / Case Study

The Latest ddPCR Technology for Mutation Detection Multiplexing

This app note highlights the latest ddPCRTM solutions for advanced assay multiplexing. It demonstrates how researchers can get the most out of precious clinical samples, with time and cost-saving advantages over gene sequencing methods.
The PTC Tempo 4848 Thermal Cycler.
Product News

Bio-Rad Launches PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers

Superior thermal performance and enhanced usability for PCR applications, such as sequencing, cloning, and genotyping.
StarBright dyes.
Product News

Bio-Rad Launches First StarBright™ Red Dye and Extends Range of Antibody Markers

Bio-Rad Laboratories announced the launch of the 29th StarBright Dye, StarBright Red 670, and an expansion of its current range. With 29 additional targets the range also includes dog, cow, and pig targets.
Illustration of DNA double helices on a yellow and pink polka dot background.
Article

Oncology Researchers: Are You Getting the Most From Your Digital PCR Data?

This article discusses what good dPCR data looks like, how substandard equipment can detract from data quality and what oncology researchers can do to get high-quality dPCR data that will provide accurate and efficient insight into tumor load.
Illustration of DNA double helices with a flame pattern in the background.
Industry Insight

Gene Expression Analysis in Cancer Research

We spoke with Bio-Rad’s Justin Barker to discover some of the challenges associated with gene expression analysis in oncology and learn about technology developments in this field.
A, G, C and T letters representing sequencing.
Industry Insight

Expanding the Short-Read Sequencing Space With Novel RNA-Sequencing Library Preparation Workflows

This article discusses the methodology of using common archived biospecimens for RNA sequencing in oncology applications, such as tumor profiling, introducing challenges and innovative solutions.
IT-Leish diagnostic test packs.
Product News

Global Access Diagnostics (GADx) Reintroduces IT-Leish, the Rapid Diagnostic Test for Visceral Leishmaniasis

Test reintroduced to the market following regulatory and performance validation for UKCA marking.
The Evolution of Wastewater-Based Epidemiology
Infographic

The Evolution of Wastewater-Based Epidemiology

For over 150 years, wastewater has provided a rich source of data for tracking infectious diseases and informing public health decisions. Since the COVID-19 pandemic, the scope for wastewater-based epidemiology (WBE) has increased significantly and requires increasingly rapid, versatile and accurate detection methods to monitor the spread of disease.
RNA molecule.
Industry Insight

Quality Control for RNA Therapeutics: Meeting a Growing Need

New applications for RNA therapeutics are continuously emerging. In this burgeoning space, nucleic acid quantification can help this dynamic therapeutic modality reach its full potential.
Current Trends and Future Prospects in Immuno-oncology content piece image
Listicle

Current Trends and Future Prospects in Immuno-Oncology

Immunotherapy aims to leverage the power of the immune system in the fight against cancer. It offers a more effective and less destructive approach than many traditional treatments.
Advertisement